GlassScriptPhysician profile
Carrie Kyper Royer
NPI 1114333572
$1,952.18
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,952.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $276.26 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $265.45 | 2021 | |
| Lilly USA, LLC | $170.66 | 2021 | |
| Esperion Therapeutics, INC. | $151.34 | 2021 | |
| Abbvie INC. | $132.10 | 2021 | |
| Merck Sharp & Dohme LLC | $130.44 | 2021 | |
| Currax Pharmaceuticals LLC | $125.34 | 2021 | |
| Glaxosmithkline, LLC. | $119.08 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $96.53 | 2021 | |
| Novo Nordisk INC | $78.41 | 2021 | |
| Sanofi-Aventis U.S. LLC | $59.97 | 2021 | |
| Amgen INC. | $59.27 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.84 | 2021 | |
| Pfizer INC. | $52.17 | 2021 | |
| Amarin Pharma, INC. | $51.28 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.11 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $24.11 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.45 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.30 | 2021 | |
| Ironwood Pharmaceuticals, INC | $15.11 | 2021 | |
| Arbor Pharmaceuticals, INC. | $13.61 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.35 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Royer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.